Skip to main content
main-content
Top

30-09-2017 | Metastatic melanoma | Article

Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study

Chapman PB et al. Ann Oncol 2017; 28(10): 2581-2587. doi:10.1093/annonc/mdx339

Please log in to get access to this content

Related topics